Psychotropic Drug Targeting: Receptors
Learn how drugs modify the actions of G-protein-coupled receptors (GPCRs) and why mutations in these genes may affect drug response, side effect rate, or drug exposure.
Pharmacodynamic (PD) Genes Introduction
Pharmacodynamic genes are genes that can affect therapeutic response or adverse effects to medications. Learn how PD gene variation affects drug response.
Management of Treatment-Resistant Depression with a Focus on Pharmacogenetics
Join Genomind’s Medical Science Liaisons as they present on Management of Treatment-Resistant Depression with a Focus on Pharmacogenetics.
The Social Media Dilemma: How Children’s Mental Health May Be Affected
Discover the positive and negative effects of social media on mental health in children of all ages and find tips on modifying social media use.
Considering Eating Disorders as Psychiatric Disorders
Eating disorders are psychiatric disorders that often coexist with other mental health difficulties such as anxiety, depression, OCD, and substance abuse.
How To Become a Mental Health Advocate
Stigma is an obstacle for many people with mental health issues. But awareness is growing. Mental health advocates have been at the heart of this change.
Sleep, Rhythms, and Genetics in Psychiatry
Genomind and guest speaker, Dr. Ruth Benca, MD, PhD, present Sleep, Rhythms, and Genetics in Psychiatry.
Introduction to the Genomind Mental Health Map
Learn about the Genomind Mental Health Map, and the 7 core genetic mental health capabilities.
CPIC: New Findings and Current Guidelines
Genomind and guest speaker, Dr. Kelly E. Caudle, PharmD, PhD, BCPS, discuss CPIC guidelines.
Dear Mom: A Story of a Family’s Mental Health Journey
Genomind’s Dear Mom brand-driven video ad campaign ranked in top 5 most-viewed wellness spots in December 2020 by Ad Age and AcuityAds.
Mental Health 360 – Genomind’s Genetic Test Offerings
Learn about Genomind’s two genetic tests, the Professional PGx Express™ and the Mental Health Map™, and how they embody the Mental Health 360™.
Integrating Mental Health PGx into Your Practice: Meet the Experts
Genomind and our panel of experts discuss the importance of integrating mental health PGx testing into your practice.
Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy & Tolerability in Children & Adolescents
Genomind and guest speaker, Dr. Jeffrey R. Strawn, MD, FAACP, present Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy and Tolerability in Children and Adolescents.
Pharmacogenetics Predictors of Methylphenidate Efficacy in Childhood ADHD
Review pharmacodynamic literature in an effort to identify clinically significant predictors of methylphenidate (MPH) response in children.
Pharmacogenetic-Informed Prescribing in Mental Health Care
Genomind and guest speaker, Dr. Chad Bousman, PhD, MPH, present pharmacogenetic-informed prescribing in mental health care.
Telepsychiatry in the Era of COVID-19
Genomind and guest speakers, Dr. Jay Fawver, Dr. Peter Yellowlees, and Jacob Harper, JD, discuss increasingly relevant topics such as how to transition to telepsychiatry in the age of COVID-19.
What Everyone Needs to Know About Drug Metabolism
How you metabolize medications is important to know for your prescription. These insights can help healthcare providers prescribe with more precision.
Genomind Launches GenMed Proâ„¢ Precision Gene-Drug Interaction Software to Revolutionize the Prescription Process
Genomind®, the leader in comprehensive genetics and digital mental health services, has announced the launch of GenMed✔ Pro™ – Precision Gene-Drug Interaction Software.
Can Genetic Testing for Medication Response Transform Mental Health Treatment?
Genetic testing for medication response can help personalize treatment for anxiety, depression, ADHD, schizophrenia, and PTSD. Learn how.
Pharmacokinetics (PK) and CYP450 Genes Introduction
Better understand pharmacokinetics (PK) and how the CYP450 gene can play a critical role in drug metabolism.
Introduction to Phenoconversion
Learn about phenoconversion, the process responsible for mismatch between the individual’s genotype-based prediction of drug metabolism and the true capacity to metabolize drugs due to non genetic factors.
Where Does Evidence for Pharmacogenetics Come From?
Get to know the principal organizations that make recommendations and guidelines on associations for gene-drug pairs.
Physiological Changes and Pediatric Pharmacokinetics
Discover why and how understanding the dynamic physiological changes that occur in the pediatric population can help to identify optimal drug dosing.
DRD2 and Antipsychotics Spotlight
Find out why the DRD2 gene, the D2 subtype of the dopamine receptor, is an important factor when considering antipsychotic medications.
BDNF Gene Spotlight
Better understand Val66Met, a nucleotide polymorphism (SNP) in the BDNF gene associated with reduced activity dependent secretion of BDNF.
MC4R Gene Spotlight
Discover the MC4R gene, which is found in the hypothalamus and involved in the regulation of satiety, food intake, and energy expenditure.
Continuing Medical Education: When, Why, and How to Integrate Pharmacogenetic Testing into Clinical Practice
Earn CME credits through a course on When, Why, and How to Integrate Pharmacogenetic Testing into Clinical Practice.
SLC6A4 and SSRIs Spotlight
Learn about the SLC6A4 gene, its relationship with SSRI response, and how having this information can impact treatment decisions.
Pharmacogenetics and its Role in the Mental Health 360 Approach
What is pharmacogenetics (PGx) and how can Genomind help you take a 360-degree approach to mental health? Find out in this introduction to PGx testing.
HT2RC Gene Spotlight
Find out why variations in the HTR2C gene are useful in considering the biological risk factors that contribute to antipsychotic induced weight gain.
